Literature DB >> 6718573

Muscle transplantation by fascicular territory.

R T Manktelow, R M Zuker.   

Abstract

In some muscles, distinct and separate portions of the muscle are each under the control of a different fascicle of the motor nerve. Although there is some slight overlap in areas, this unit, a single fascicle muscle territory, is present in the gracilis muscle. Microneurovascular techniques have improved the reliability of muscle transplantation for the reconstruction of facial paralysis. The amount of movement obtained depends on many factors, including the amount of muscle transplanted and the adequacy of its reinnervation. The ability to transplant a small segment of a muscle based on the fascicular territory enables the surgeon to supply the amount of movement that each individual patient requires.

Entities:  

Mesh:

Year:  1984        PMID: 6718573     DOI: 10.1097/00006534-198405000-00005

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

Review 1.  Functional reconstruction after facial paralysis: a survey.

Authors:  A Berger; H J Bargmann
Journal:  World J Surg       Date:  1990 Nov-Dec       Impact factor: 3.352

2.  Plastic surgery: facial palsy.

Authors:  D S Sellers; S H Miller
Journal:  West J Med       Date:  1986-10

3.  Facial reinnervation after facial paralysis: is it ever too late?

Authors:  N B Gagnon; P Molina-Negro
Journal:  Arch Otorhinolaryngol       Date:  1989

4.  Use of gastrointestinal anastomosis stapler for harvest of gracilis muscle and securing it in the face for facial reanimation: a novel technique.

Authors:  Sachin M Shridharani; Sahael M Stapleton; Richard J Redett; Michael Magarakis; Gedge D Rosson
Journal:  Eplasty       Date:  2010-04-08

Review 5.  [Free functional gracilis muscle transplantation for reconstruction of active elbow flexion in posttraumatic brachial plexus lesions].

Authors:  Alfred Berger; Robert Hierner
Journal:  Oper Orthop Traumatol       Date:  2009-06       Impact factor: 1.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.